Skip to main content

Peer Review reports

From: A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies

Original Submission
18 Mar 2014 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Publishing
27 Feb 2015 Editorially accepted
23 Mar 2015 Article published 10.1186/s12885-015-1146-8

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us